Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenoma D000236 40 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia D000740 21 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Fabry Disease D000795 4 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Edema D004487 152 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Eye Abnormalities D005124 7 associated lipids
Fibrosis D005355 23 associated lipids
Glioblastoma D005909 27 associated lipids
Glioma D005910 112 associated lipids
Heart Failure D006333 36 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Influenza, Human D007251 11 associated lipids
Insulin Resistance D007333 99 associated lipids
Insulinoma D007340 28 associated lipids
Leukemia D007938 74 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Lung Neoplasms D008175 171 associated lipids
Melanoma D008545 69 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Cardiomyopathies D009202 10 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Jin YX et al. A strategy for enrichment of the bioactive sphingoid base-1-phosphates produced by Hypericum perforatum L. in a balloon type airlift reactor. 2012 Bioresour. Technol. pmid:22940331
Yu FX et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. 2012 Cell pmid:22863277
Snider AJ et al. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. 2012 Prostaglandins Other Lipid Mediat. pmid:22940715
Moon MH et al. Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. 2012 Int. J. Mol. Med. pmid:22992945
Park TS and Goldberg IJ Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. 2012 Heart Fail Clin pmid:22999245
Ihlefeld K et al. Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. 2012 Biochem. J. pmid:22908849
Wang ZY et al. [Effect of sphingosine 1-phosphate/sphingosine 1-phosphate receptor signal pathway on function of neutrophils]. 2012 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22931670
Miller E et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. 2012 Chem. Biol. pmid:22884261
Cannon RE et al. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22949658
Richerioux N et al. Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek's Disease Virus. 2012 PLoS ONE pmid:22952878
He S et al. Self-amplification mechanisms of mast cell activation: a new look in allergy. 2012 Curr. Mol. Med. pmid:22920722
Hisano Y et al. The functional roles of S1P in immunity. 2012 J. Biochem. pmid:22923732
Aoyagi T et al. The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. 2012 Lymphat Res Biol pmid:22984905
Chiba K and Yoshii N [Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis]. 2012 Nippon Yakurigaku Zasshi pmid:22728990
Linke B et al. Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation. 2012 Prostaglandins Other Lipid Mediat. pmid:22732087
Yokoyama K et al. Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. 2012 Clin. Nephrol. pmid:22732343
Czarnota GJ et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22778441
Upadhyaya P et al. The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. 2012 Biochem. Biophys. Res. Commun. pmid:22727907
Boussommier-Calleja A et al. Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. 2012 Invest. Ophthalmol. Vis. Sci. pmid:22807298
Kharel Y et al. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. 2012 Biochem. J. pmid:22747486
Zhang BL et al. Sphingosine 1-phosphate acts as an activator for the porcine Gpr3 of constitutively active G protein-coupled receptors. 2012 J Zhejiang Univ Sci B pmid:22761247
Park SW et al. Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. 2012 J. Am. Soc. Nephrol. pmid:22095950
Kotelevets N et al. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis. 2012 PLoS ONE pmid:22761740
Nakahara T et al. Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. 2012 Fertil. Steril. pmid:22763095
Nijnik A et al. The role of sphingosine-1-phosphate transporter Spns2 in immune system function. 2012 J. Immunol. pmid:22664872
Liu X et al. Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells. 2012 Mol. Cell. Biochem. pmid:22113622
Liu X et al. ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate. 2012 Clin. Chim. Acta pmid:22115863
Juarez JG et al. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. 2012 Blood pmid:22049516
Pennington LD et al. Quinolinone-based agonists of S1P₁: use of a N-scan SAR strategy to optimize in vitro and in vivo activity. 2012 Bioorg. Med. Chem. Lett. pmid:22104144
Milara J et al. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. 2012 Thorax pmid:22106015
Raje MR et al. Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors. 2012 Bioorg. Med. Chem. pmid:22137932
Lu H et al. Senescent endothelial dysfunction is attributed to the up-regulation of sphingosine-1-phosphate receptor-2 in aged rats. 2012 Mol. Cell. Biochem. pmid:22139303
Fujii Y et al. Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities. 2012 J. Immunol. pmid:22131329
Ishimaru N et al. CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy. 2012 Am. J. Pathol. pmid:22067914
Krishna SM et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. 2012 Am. J. Pathol. pmid:22698985
Lee SH et al. Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. 2012 J. Clin. Endocrinol. Metab. pmid:22679064
Ponnusamy S et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. 2012 EMBO Mol Med pmid:22707406
Kunisawa J and Kiyono H Immunological function of sphingosine 1-phosphate in the intestine. 2012 Nutrients pmid:22666543
Yang J et al. Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling. 2012 Circulation pmid:22668972
Li C et al. Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor. 2012 J. Neurophysiol. pmid:22673325
Watson L et al. Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. 2012 J. Clin. Immunol. pmid:22648459
Sato C et al. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation. 2012 Biochem. Biophys. Res. Commun. pmid:22659743
Tencé M et al. Increased interaction of connexin43 with zonula occludens-1 during inhibition of gap junctions by G protein-coupled receptor agonists. 2012 Cell. Signal. pmid:21872657
Farahat WA et al. Ensemble analysis of angiogenic growth in three-dimensional microfluidic cell cultures. 2012 PLoS ONE pmid:22662145
Somers SJ et al. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. 2012 Cardiovasc Drugs Ther pmid:22392184
Chakraborty G et al. Ethanol triggers sphingosine 1-phosphate elevation along with neuroapoptosis in the developing mouse brain. 2012 J. Neurochem. pmid:22393932
Schnute ME et al. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. 2012 Biochem. J. pmid:22397330
Bachmaier K et al. Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin. 2012 PLoS ONE pmid:22355325
Lucki NC and Sewer MB Nuclear sphingolipid metabolism. 2012 Annu. Rev. Physiol. pmid:21888508
Duru EA et al. SRC regulates sphingosine-1-phosphate mediated smooth muscle cell migration. 2012 J. Surg. Res. pmid:21920544
Belvitch P and Dudek SM Role of FAK in S1P-regulated endothelial permeability. 2012 Microvasc. Res. pmid:21925517
Liu Q et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. 2012 PLoS ONE pmid:22848628
Asghar MY et al. Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. 2012 Endocr. Relat. Cancer pmid:22889737
Kim BJ et al. Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women. 2012 J. Clin. Endocrinol. Metab. pmid:22879631
Knapp M et al. Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat. 2012 Lipids pmid:22833182
Brizuela L et al. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. 2012 Mol. Cancer Ther. pmid:22784711
Japtok L et al. Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. 2012 PLoS ONE pmid:23145172
Zhang L et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. 2012 J. Exp. Med. pmid:23148237
Qiao Y et al. Sphingosine 1-phosphate elicits proinflammatory responses in ARPE-19 cells. 2012 Invest. Ophthalmol. Vis. Sci. pmid:23150617
Mendoza A et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. 2012 Cell Rep pmid:23103166
Kurek K et al. [Role of sphingolipids in digestive system]. 2012 Postepy Hig Med Dosw (Online) pmid:23175343
Wilkerson BA et al. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. 2012 J. Biol. Chem. pmid:23135269
Tar L and Vécsei L [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism]. 2012 Ideggyogy Sz pmid:23136726
Spohr TC et al. Sphingosine 1-phosphate-primed astrocytes enhance differentiation of neuronal progenitor cells. 2012 J. Neurosci. Res. pmid:22588662
Parrill AL et al. Structure of the first sphingosine 1-phosphate receptor. 2012 Sci Signal pmid:22623751
Trifilieff A and Fozard JR Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. 2012 J. Pharmacol. Exp. Ther. pmid:22570366
Van Brocklyn JR and Williams JB The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. 2012 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:22613819
Loh KC et al. Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. 2012 PLoS ONE pmid:22606352
Okada T and Nakamura S [Role of S1P acting both inside and outside the cells]. 2012 Seikagaku pmid:22550899
Brizuela L and Cuvillier O Biochemical methods for quantifying sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphate. 2012 Methods Mol. Biol. pmid:22528435
Pitman MR et al. Isoform-selective assays for sphingosine kinase activity. 2012 Methods Mol. Biol. pmid:22528436
Bode C and Gräler MH Quantification of sphingosine-1-phosphate and related sphingolipids by liquid chromatography coupled to tandem mass spectrometry. 2012 Methods Mol. Biol. pmid:22528437
Morishige J et al. A cleanup method for mass spectrometry of sphingosine-1-phosphate in blood and solid tissues using a phosphate capture molecule. 2012 Methods Mol. Biol. pmid:22528438
Visentin B et al. Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples. 2012 Methods Mol. Biol. pmid:22528439
Obinata H and Hla T Assessment of sphingosine-1-phosphate activity in biological samples by receptor internalization and adherens junction formation. 2012 Methods Mol. Biol. pmid:22528440
Medlin MD et al. Quantifying sphingosine-1-phosphate-dependent activation of the RhoGTPases. 2012 Methods Mol. Biol. pmid:22528442
Belmonte SA and Suhaiman L Optimized protocols to analyze sphingosine-1-phosphate signal transduction pathways during acrosomal exocytosis in human sperm. 2012 Methods Mol. Biol. pmid:22528443
Knapp M et al. Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. 2012 Basic Res. Cardiol. pmid:22961594
Shea BS and Tager AM Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. 2012 Proc Am Thorac Soc pmid:22802282
Morel S et al. The natural cardioprotective particle HDL modulates connexin43 gap junction channels. 2012 Cardiovasc. Res. pmid:21960685
Su G et al. Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. 2012 Am. J. Respir. Crit. Care Med. pmid:21980034
Nakahara K et al. The Sjögren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. 2012 Mol. Cell pmid:22633490
Castillo-Badillo JA et al. Sphingosine 1-phosphate-mediated α1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions. 2012 Biochim. Biophys. Acta pmid:22019450
Christopherson KW PBSCs Sphingoling along S1P/S1P1 axis. 2012 Blood pmid:22262738
Fujii Y et al. Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P. 2012 Biochim. Biophys. Acta pmid:22265714
Dakroub Z and Kreydiyyeh SI Sphingosine-1-phosphate is a mediator of TNF-α action on the Na+/K+ ATPase in HepG2 cells. 2012 J. Cell. Biochem. pmid:22271589
Santulli P et al. Sphingosine pathway deregulation in endometriotic tissues. 2012 Fertil. Steril. pmid:22277765
Tse KW et al. Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells. 2012 Jan-Feb Cell. Immunol. pmid:22507871
Fournie P et al. Sphingosine-1 phosphate prevents ethanol-induced corneal epithelial apoptosis. 2012 Mar-Apr Indian J Ophthalmol pmid:22446906
Iwaki S et al. Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22819712
Takuwa Y et al. Sphingosine-1-phosphate signaling in physiology and diseases. 2012 Sep-Oct Biofactors pmid:22674845
Cortez-Retamozo V et al. Angiotensin II drives the production of tumor-promoting macrophages. 2013 Immunity pmid:23333075
Takuwa Y et al. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22735357
Kunkel GT et al. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. 2013 Nat Rev Drug Discov pmid:23954895
Moriue T et al. Sphingosine 1-phosphate attenuates peroxide-induced apoptosis in HaCaT cells cultured in vitro. 2013 Clin. Exp. Dermatol. pmid:23837937
Kager LM et al. Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis). 2013 J. Thromb. Haemost. pmid:23216621
Liang J et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. 2013 Cancer Cell pmid:23273921
Cartwright TA et al. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. 2013 J. Cereb. Blood Flow Metab. pmid:23168528
Willis MA and Cohen JA Fingolimod therapy for multiple sclerosis. 2013 Semin Neurol pmid:23709211
Tatematsu S et al. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23723371